Amedisys Inc Stock News

The best long-term stocks feature stable earnings growth and steady price gains. Here's how to find, buy and sell them — and a list to get you started.

Amedisys receives cash payment of $96M in CARES Act assitance AMED

The COVID-19 pandemic staggered economic activity and decreased consumer spending. Some companies have benefited from the extra resources needed to help curb the pandemic and keep...

Is (AMED) Outperforming Other Medical Stocks This Year?

Is (AMED) Outperforming Other Medical Stocks This Year?

To safeguard one's portfolio from notable losses, the real challenge for an investor is determining whether the organization's debt level is sustainable. A debt-free corporation is hard to find.

On Thursday morning, 49 companies hit new 52-week highs. Noteworthy Mentions: Amazon.com (NASDAQ: AMZN) was the largest firm on a market cap basis to set a new 52-week...

Shares of Amedisys Inc (NASDAQ:AMED) reached a new 52-week high on Tuesday . The company traded as high as $205.88 and last traded at $205.88, with a volume of 921 shares trading hands. The stock had

After the April 2 follow-through day on the S&P; 500 and the April 6 Tom Petty "Won't Back Down" FTD on the Nasdaq, we are making some updates to IBD's Long-Term Leaders Portfolio and Watchlist. Th

Does Amedisys (AMED) have what it takes to be a top stock pick for momentum investors? Let's find out.

Amedisys (AMED) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Does Amedisys (AMED) have what it takes to be a top stock pick for momentum investors? Let's find out.

Amedisys, a nursing home care provider, broke out over a 202.86 entry after clearing an early entry at 190.50 last week. This was an outside day for a long-term leader.

Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.